Navigation Links
Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
Date:8/3/2009

ucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the value of its products in the market (including MuGard and the size of the overall market for mucositis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
2. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
3. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
4. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
5. First U.S. Patients Enrolled in the REALISM Continued Access Study
6. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
7. Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries
8. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
9. Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
10. St. Jude Study Gives New Insights Into How Cells Accessorize Their Proteins
11. McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... BOSTON , Oct. 1, 2014   ... market-leading provider of Anesthesia Information Management Systems (AIMS), ... Systems, LLC , a wholly owned subsidiary of ... healthcare information systems and connectivity solutions.  ... http://photos.prnewswire.com/prnh/20140930/149407 This partnership ...
(Date:10/1/2014)... NeuroCall, Inc., ("NeuroCall") announced today that it ... Teleneurology services. Dr. Ricardo Garcia-Rivera , Founder and ... proud that our quality of service has been recognized ... lifesaving support and continuity of care to patients of ... the United States ." NeuroCall ...
(Date:10/1/2014)... , Oct. 1, 2014 Quantum ... scaling volume production of photoactive quantum dots for ... . While offering numerous advantages for solar power ... large quantities of quantum dots with which to ... kept them from commercial utilization and acceptance. The ...
Breaking Medicine Technology:Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3NeuroCall Awarded Joint Commission Accreditation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3
... 2011 Smith & Nephew Orthopaedics (NYSE: ... agreement with French biotechnology company Graftys. The deal gives ... calcium phosphate bone void filler in the U.S., and ... "We are committed to offering our surgeon customers innovative ...
... (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, ... ended March 31, 2011. In the ... increased $1,031,003 to $2,284,552, up 82% compared to the ... strength in its prescription business and the acquisition of ...
Cached Medicine Technology:Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys 2Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys 3HealthWarehouse.com Reports 82% Quarter-Over-Quarter Revenue Growth in the First Quarter 2011 2
(Date:10/1/2014)... 2014 Anti Aging Clinic (AntiAgingClinic.ca), the ... destination of choice, is announcing a discounted cost on ... December. , “We’re doing this because we want to ... top skin clinic in Toronto,” says Dr. Brian Sieber, ... at Anti Aging Clinic, including laser facials, genesis laser ...
(Date:10/1/2014)... in Bahir Dar, Ethiopia, at the occasion of ... gathered some 150 African and international leishmaniasis experts, ... safety and efficacy monitoring plan, carried out ... Sudan, Uganda, and Ethiopia, were presented to key ... to treatment of kala-azar with the combination of ...
(Date:10/1/2014)... October 01, 2014 Woodland Hills ... to a group of dental specialists who treat full ... Spain city of Oviedo. Dr. Reshad of the Anacapa ... with clients on two continents, will give a full-day ... full mouth reconstruction. , “These specialists want to improve ...
(Date:10/1/2014)... WA (PRWEB) October 01, 2014 Two ... will take them across the country in an effort ... today’s military families. The cyclists, a father-daughter team, ... states, beginning in Blaine, Washington and finishing in Key ... benefit Hope For The Warriors®, a national nonprofit organization ...
(Date:10/1/2014)... 2014 UP4 Probiotics will be donating ... to The National Network to End Domestic Violence ( ... was chosen through nationwide polling that took place during ... outlets. , “We are proud to have been ... every sale of UP4 Women’s Probiotics during the month ...
Breaking Medicine News(10 mins):Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4Health News:Father-Daughter Cycling Duo to Ride Cross-Country to Benefit Hope For The Warriors 2Health News:UP4 Probiotics Partners with The National Network to End Domestic Violence 2
... Benefits, DALLAS, April 17 Affiliated Computer,Services, ... it has successfully,completed Phase I of the Government ... to attain the highest quality patient,care for the ... key technology partner, ACS has installed,state-of-the-art IT infrastructure ...
... identification of the dangerous disease , , WEDNESDAY, April 16 ... to accurately, rapidly, and non-invasively diagnose lung cancer with ... a new study suggests. , Oral cavity tissue damage ... a highly accurate indicator of similar lung tissue damage ...
... Calorie Information, ALEXANDRIA, Va., April 16 ... ruling upholding,a New York City regulation that requires ... on their menus and menu boards. This ruling ... filed by the New York State,Restaurant Association. The ...
... N.C., April 16 MedCath Corporation,(Nasdaq: MDTH ) ... its Board of Directors., Mr. Grossman brings a ... Board of Directors. He served as partner and health ... 2005,after 37 years with the firm. While with Pricewaterhouse ...
... trusted and global orthopaedics corporation and the developer of ... in the field, is pleased to announce that the ... nominated for the European Patent Offices Inventor of the ... still in school when he lost his foot in ...
... & H.B. 5285 Enables BCBSM to expand ... its Monopoly rather than Lower Rates, LANSING, Mich., ... the Blues to expand their unfair advantage into,a monopoly rather than ... & Competitive Insurance Market. The Coalition,represents a group of Michigan based, ...
Cached Medicine News:Health News:ACS Systems Improving Delivery of Healthcare in Malta 2Health News:ACS Systems Improving Delivery of Healthcare in Malta 3Health News:Mouth Swab May One Day Diagnose Lung Cancer 2Health News:Mouth Swab May One Day Diagnose Lung Cancer 3Health News:Statement of the American Diabetes Association Supporting Federal Court's Ruling on New York City Proposal 2Health News:Woodrin 'Woody' Grossman Appointed to MedCath's Board of Directors 2Health News:Inventor of Ossur's Flex-foot nominated for European Inventor of the Year 2008 2Health News:Coalition For A Fair & Competitive Insurance Market Says Senate Should Reject the Blues Attempt to Expand Their Unfair Advantage 2Health News:Coalition For A Fair & Competitive Insurance Market Says Senate Should Reject the Blues Attempt to Expand Their Unfair Advantage 3Health News:Coalition For A Fair & Competitive Insurance Market Says Senate Should Reject the Blues Attempt to Expand Their Unfair Advantage 4
... LH 755 simplifies and automates ... expert automation and advanced technologies ... reliable, accurate results every time. ... slide quality with its slide-on-slide ...
Kinetic and endpoint methods for the quantitative determination of creatinine in serum....
For the quantitative determination of creatine kinase-MB in serum. Kinetic Reaction measured at 340 nm. Linearity: 700 IU/L at 37C....
Intended for the quantitative determination of magnesium in serum. Wavelength: 340 nm. Linearity: 9.7 mg/dL (4 mmol/L). Two vials, dry powder reagents....
Medicine Products: